Year archive

NervGen Pharma Corp. — 2020 filings

All 48 regulatory filings released by NervGen Pharma Corp. (NGEN) in 2020, sourced directly from the official regulator.

48 Filings

2020 Period

2020 filings (48)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2020-10-28	English
News release - English.pdf Regulatory Filings	2020-10-02	English
Material change report - English.pdf Regulatory Filings	2020-09-12	English
News release - English.pdf Regulatory Filings	2020-09-10	English
Form of proxy - English.pdf Regulatory Filings	2020-09-02	English
Notice of meeting - English.pdf Regulatory Filings	2020-09-02	English
Other.pdf Regulatory Filings	2020-09-02	English
Other.pdf Regulatory Filings	2020-09-02	English
Management information circular - English.pdf Regulatory Filings	2020-09-02	English
News release - English.pdf Regulatory Filings	2020-08-21	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-08-21	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-08-21	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-08-21	English
Interim MD&A - English.pdf Regulatory Filings	2020-08-21	English
Material change report - English.pdf Regulatory Filings	2020-08-19	English
News release - English.pdf Regulatory Filings	2020-08-10	English
News release - English.pdf Regulatory Filings	2020-08-04	English
Consent letter of issuer's legal counsel.pdf Regulatory Filings	2020-08-01	English
Amendment to prospectus (non pricing) supplement – English.pdf Regulatory Filings	2020-08-01	English
Auditors' consent letter.pdf Regulatory Filings	2020-08-01	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2020-07-31	English
News release - English.pdf Regulatory Filings	2020-07-27	English
News release - English.pdf Regulatory Filings	2020-07-23	English
Marketing materials - English.pdf Regulatory Filings	2020-07-22	English
News release - English.pdf Regulatory Filings	2020-06-22	English
Report of exempt distribution excluding schedule 1 of Form 5 (amended).pdf Regulatory Filings	2020-06-04	English
News release - English.pdf Regulatory Filings	2020-06-03	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2020-06-02	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2020-06-02	English
News release - English.pdf Regulatory Filings	2020-06-01	English
News release - English.pdf Regulatory Filings	2020-06-01	English
Interim MD&A - English.pdf Regulatory Filings	2020-06-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-06-01	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-06-01	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-06-01	English
Interim MD&A - English.pdf Regulatory Filings	2020-06-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-06-01	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-06-01	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-06-01	English
Material change report - English.pdf Regulatory Filings	2020-05-22	English
Material change report - English.pdf Regulatory Filings	2020-04-14	English
News release - English.pdf Regulatory Filings	2020-02-27	English
News release - English.pdf Regulatory Filings	2020-02-24	English
News release - English.pdf Regulatory Filings	2020-01-13	English
Decision Document (Final).pdf Regulatory Filings	2020-01-03	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2020-01-02	English
Final short form prospectus – English.pdf Regulatory Filings	2020-01-02	English
Auditors' consent letter.pdf Regulatory Filings	2020-01-02	English